WebInovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human … WebInovio Pharmaceuticals market cap history and chart from 2010 to 2024. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding.

News INOVIO PHARMACEUTICALS Stock Price Today - Insider

WebAccording to Inovio Pharmaceuticals 's latest financial reports the company's current revenue (TTM) is $10.26 M . In 2024 the company made a revenue of $1.77 M a decrease … WebApr 11, 2024 · INOVIO's DNA medicines in development are delivered using its investigational proprietary smart device, CELLECTRA ®, to produce immune responses against targeted pathogens and cancers. For more information, visit www.inovio.com. Contacts Media: Jennie Willson (267) 429-8567 [email protected] infotrading srl

INO Inovio Pharmaceuticals Inc. Stock Price & News - WSJ

WebApr 4, 2024 · The company focuses on DNA medicines to treat HPV diseases, cancer, and infectious diseases. Inovio has no marketed products. Motley Fool Issues Rare “All In” Buy … WebAs of March 2024 Inovio Pharmaceuticals has a market cap of $0.23 Billion . This makes Inovio Pharmaceuticals the world's 5997th most valuable company by market cap … WebJan 3, 2024 · Inovio Pharmaceuticals (NASDAQ:INO) adds US$37m to market cap in the past 7 days, though investors from a year ago are still down 69% Simply Wall St January 3, … mita bay campground